Sylvester researchers target treatment-resistant prostate cancer with oral chemo in preclinical study – The Cancer Letter

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have developed an orally administered drug to disrupt prostate cancer cells’ metabolism and deliver the chemotherapy agent cisplatin directly into treatment-resistant prostate cancer cells. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login?…

Read the full article here

Source: The Cancer Letter

Categories: Hem/Onc News and Journals, Latest Headlines

Tweets with this article

The Cancer Letter

.@SylvesterCancer researchers target treatment-resistant prostate cancer with oral chemo in preclinical study. https://t.co/qzKV7178Zx https://t.co/31WkPuCsr0

NCI: Cancer center communicators are key to the success of the National Cancer Plan – The Cancer Letter

Cancer center communicators—public relations, marketing, and communications experts—are indispensable players in the implementation of the National Cancer Plan, said Peter Garrett, director of NCI’s Office…

The Cancer Letter May 24, 2024

Are we focused on the wrong risk type in genetic screening? Breast cancer screening study shows new paths to population screening – The Cancer Letter

A common perception of genetic screening is that only individuals at high risk of certain diseases will be identified. To access this subscriber-only content please log…

The Cancer Letter May 24, 2024

As House prepares cuts for NIH, Rathmell urges Senate to protect funding in FY25 – The Cancer Letter

NCI Director Kimryn Rathmell joined the NIH director and four other institute directors in a May 23 Senate subcommittee hearing to craft the Labor-HHS spending…

The Cancer Letter May 24, 2024

Training programs for medical educators can overcome barriers in global oncology How an education program in Ethiopia increased access to cancer pain management – The Cancer Letter

Teachers who master their craft know this secret: They will not meet some of their pupils. To access this subscriber-only content please log in or…

The Cancer Letter May 24, 2024

Related Articles